For InvestorsAntares Pharma: Making Medicines Feel Better

Press Release Archive

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

2019

28 Feb 2019
ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2018 OPERATING AND FINANCIAL RESULTS

27 Feb 2019
Antares Pharma to Present at the Raymond James & Associates 40TH Annual Institutional Investors Conference

28 Feb 2019
Antares Pharma Reports Fourth Quarter And Full Year 2018 Operating and Financial Results

04 Mar 2019
Dr. Karen Smith joins the Antares board

28 Mar 2019
Antares Pharma Announces Receipt of Orphan Drug Designation For The Treatment of Ectopic Pregnancy With Methotrexate

18 Apr 2019
Antares Pharma to Report First Quarter 2019 Financial and Operating Results

02 May 2019
Antares Pharma Reports First Quarter 2019 Operating and Financial Results

16 May 2019
Antares Pharma to Present at the B.Riley FBR Institutional Investor Conference

30 May 2019
Antares Pharma to Present at the Jefferies 2019 Healthcare Conference

27 Jun 2019
Antares Pharma Announces Amendment To Existing Loan And Security Agreement With Hercules Capital

30 Jul 2019
Antares Pharma To Report Second Quarter 2019 Financial and Operating Results

06 Aug 2019
Antares Pharma Reports Second Quarter 2019 Operating and Financial Results

20 Aug 2019
Antares Pharma partner Teva Pharmaceuticals issued a press release dated August 20,2019, relating to our partnership with Teva on the generic Epipen Jr.® - read the news regarding product availability.

17 Sep 2019
Antares Pharma To Present at the Ladenburg Thalmann 2019 Healthcare Conference

24 Oct 2019
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting

29 Oct 2019
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results

31 Oct 2019
Antares Pharma Announces Receipt of Final Payment from Sale of Zomajet™ Needle-Free Delivery System

05 Nov 2019
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results

13 Nov 2019
Antares Pharma To Present at the Jefferies 2019 London Healthcare Conference

19 Nov 2019
Antares Pharma Enters Into a Global Development Agreement with Idorsia Pharmaceuticals Ltd.

For Investors

Press Archive

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014


  • Sign up for breaking news on ATRS

    * indicates required